SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-19-005667
Filing Date
2019-09-05
Accepted
2019-09-05 16:41:56
Documents
2
Period of Report
2019-09-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-45627.html 3  
1 PRIMARY DOCUMENT marketforms-45627.xml 3 1710
2 POA DOCUMENT poa.htm EX-24 3103
  Complete submission text file 0001214659-19-005667.txt   6137
Mailing Address 5 ASHWOOD LANE MALVERN PA 19435
Business Address
Amado Rafael (Reporting) CIK: 0001662119 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38693 | Film No.: 191077589

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)